Examkin

Question

Difficulty: HardGynecologic Oncology

A 6565-year-old woman comes to the clinic reporting a single episode of bright red blood on her undergarments two days ago. She has not had a menstrual period in fourteen years. Her medical history is notable for obesity, type 2 diabetes mellitus, and severe genitourinary syndrome of menopause. Three weeks ago, she began using a low-dose estradiol vaginal ring for her genitourinary symptoms. Her body mass index is 33 kg/m233\text{ kg/m}^2. Vital signs are within normal limits. Pelvic examination reveals a correctly positioned vaginal ring, improved mucosal hydration, and no visible lacerations or active bleeding in the vaginal vault. Ultrasound imaging of the pelvis demonstrates a homogeneously thickened uterine stripe measuring 7 mm7\text{ mm} and bilateral normal-appearing adnexa. Which of the following is the most appropriate next step in management?

  1. Histologic sampling of the uterine lining in the officeAnswer
  2. B
    Discontinuation of the vaginal ring and clinical observation
  3. C
    Empiric trial of cyclic oral progestin therapy
  4. D
    Operative hysteroscopy with targeted tissue removal
  5. E
    Repeat transvaginal ultrasonography in three months

Answer

Histologic sampling of the uterine lining in the office
The correct answer is histologic sampling of the uterine lining in the office. Postmenopausal bleeding is a classic presenting symptom of endometrial carcinoma. In this patient, despite the recent initiation of a low-dose estradiol vaginal ring (which can occasionally cause minor spotting), her presentation must be evaluated rigorously. Transvaginal ultrasound shows an endometrial thickness of 7 mm7\text{ mm}. Guidelines mandate that an endometrial thickness greater than 4 mm4\text{ mm} in a postmenopausal woman with bleeding requires tissue sampling to rule out endometrial hyperplasia or cancer. Office-based sampling is highly sensitive, cost-effective, and avoids the risks of general anesthesia, making it the preferred initial diagnostic step.

Step-by-Step Solution

1
Evaluate the patient's presenting symptom and risk factors.
The patient has postmenopausal bleeding (PMB) with significant risk factors for endometrial cancer, including obesity and type 2 diabetes mellitus.
PMB is a cardinal sign of endometrial malignancy and requires rigorous evaluation, especially in patients with unopposed estrogen risk factors like obesity.
2
Analyze the transvaginal ultrasound (TVUS) findings.
The endometrial stripe measures 7 mm7\text{ mm}.
Current guidelines state that an endometrial thickness >4 mm>4\text{ mm} in a postmenopausal woman with bleeding is abnormal and raises strong suspicion for endometrial hyperplasia or carcinoma.
3
Determine the appropriate diagnostic intervention.
Office-based histologic sampling is indicated.
Regardless of concurrent treatments (such as a vaginal estrogen ring) that might occasionally cause local trauma or spotting, an abnormally thickened endometrium in the setting of PMB mandates a definitive tissue biopsy to rule out cancer.

Key Concept

Evaluation and diagnostic threshold for postmenopausal bleeding
Estimated Time:1m 30s
Rate this question

Topics

Gynecologic Oncology

More questions from this topic